Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Safety questions for AAV gene therapy

Charles P Venditti¹

¹National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. venditti@mail.nih.gov.

Nature Biotechnology

|November 17, 2020

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Optimization of systemic AAV9 gene therapy in Niemann-Pick disease, type C1 mice.

Life science alliance·2026

Same author

Prevalence of Neutralizing Antibodies to AAV2 and AAV9 in Individuals with Niemann-Pick Disease, Type C1.

Human gene therapy·2025

Same author

Adeno-Associated Virus Gene Therapy Development: Early Planning and Regulatory Considerations to Advance the Platform Vector Gene Therapy Program.

Human gene therapy·2025

Same author

Optimization of systemic AAV9 gene therapy in Niemann-Pick disease type C1 mice.

bioRxiv : the preprint server for biology·2024

Same author

Intellectual disability and autism in propionic acidemia: a biomarker-behavioral investigation implicating dysregulated mitochondrial biology.

Molecular psychiatry·2024

Same author

Gene therapy for organic acidemias: Lessons learned from methylmalonic and propionic acidemia.

Journal of inherited metabolic disease·2023